Specify a stock or a cryptocurrency in the search bar to get a summary
biote Corp
BTMDbiote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas. Address: 1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038
Analytics
WallStreet Target Price
9.59 USDP/E ratio
11.12Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BTMD
Dividend Analytics BTMD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BTMD
Stock Valuation BTMD
Financials BTMD
Results | 2019 | Dynamics |